Drug Type Small molecule drug |
Synonyms Certonal, Kollateral, Sorbosan |
Target |
Action inhibitors |
Mechanism Phosphodiesterases, 3',5'-cyclic nucleotide (PDEs) inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC20H22ClNO2 |
InChIKeyDULZSDGCXSLVAQ-UHFFFAOYSA-N |
CAS Registry1163-37-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08238 | Moxaverine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cardiovascular Diseases | - | - | - |
Muscle Spasticity | - | - | - |
Phase 4 | 12 | Polyethylene Glycols+Magnesium Citrate Oral Liquid Product+Bisacodyl 10 mg Suppository+Docusate Sodium 100 Mg oral capsule [Colace]+Naloxegol Oral Tablet+Senna 217 Mg Oral Tablet+Methylnaltrexone (Naloxegol Oral Tablet) | ibymwrdaoq(morkhtzxgh) = zdczjbifxz lpwuuschhz (dbdcpmfvoj, 25) View more | - | 16 Feb 2023 | ||
Placebo Oral Tablet+Magnesium Citrate Oral Liquid Product+Bisacodyl 10 mg Suppository+Docusate Sodium 100 Mg oral capsule [Colace]+Senna 217 Mg Oral Tablet+Methylnaltrexone (Placebo Oral Tablet) | ibymwrdaoq(morkhtzxgh) = jvxdevwguz lpwuuschhz (dbdcpmfvoj, 25) View more | ||||||
Phase 2 | 16 | raebjnxuht(qdplyueliu) = ayduviiwbi nvkoiemgnn (yqfwmbjhcb ) View more | Positive | 01 May 2008 |